Intralipid and inappropriate device programming Patient Reports February 13, 2012

Intralipid Side Effects Report #5825134-6
Intralipid side effect was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2008. Female patient was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: blood glucose increased, inappropriate device programming, metabolic function test abnormal. Intralipid dosage: 840 ML, 1 IN 1 HR, INTRAVENOUS DRIP. During the same period patient was treated with PROTEIN, DEXTROSE, POTASSIUM, CALCIUM, MAGNESIUM, PHOSPHATE, TRACE ELEMENTS. Patient recovered.